Skip to main content
. 2022 Apr 20;11(4):239–250. doi: 10.1302/2046-3758.114.BJR-2021-0226.R1

Table I.

Patient characteristics.

Characteristic Data (n = 102)
Median age, yrs (IQR) 28 (23 to 35)
Female, n (%) 32 (31.4)
Race/ethnicity, n (%)
White/Caucasian 48 (47.1)
Black/African-American 47 (46.1)
Hispanic/Latino 5 (4.9)
South Asian 1 (1.0)
East Asian 1 (1.0)
Fracture location, n (%)
Tibia 41 (40.2)
Femur 61 (59.8)
Open fracture, n (%) 27 (26.5)
Soft-tissue injury, n (%)
Gustilo Type I 14 (13.7)
Gustilo Type II 13 (12.7)
Tscherne Class 0 18 (17.6)
Tscherne Class 1 42 (41.2)
Tscherne Class 2 12 (11.8)
Tscherne Class 3 3 (2.9)
Additional fractures, n (%) 47 (46.1)
Upper limb 16 (15.7)
Lower limb 32 (31.4)
Spine 9 (8.8)
Median serum albumin, g/dl (IQR) 4.30 (4.00 to 4.60)
Median serum 25(OH)D, μg/l (IQR) 18.4 (13.4 to 25.6)
Vitamin D deficient, 25(OH)D < 20 μg/l, n (%) 57 (55.9)
Median CTX, μg/l (IQR) 0.34 (0.27 to 0.46)
Median P1NP, μg/l (IQR) 41.1 (30.0 to 55.0)

CTX, C-terminal telopeptide of type I collagen; IQR, interquartile range; P1NP, N-terminal propeptide of type I procollagen.